Literature DB >> 22886538

Thiazide and thiazide-like diuretics: an opportunity to reduce blood pressure in patients with advanced kidney disease.

Feras Karadsheh1, Matthew R Weir.   

Abstract

Thiazide and thiazide-like diuretics have been widely used as blood pressure-lowering agents for more than 5 decades. However, their use in patients with advanced chronic kidney disease has been limited and often discouraged. The exact mechanism of how thiazide and thiazide-like diuretics lower blood pressures is still in question. Emerging evidence suggests that thiazides and thiazide-like diuretics are effective as blood pressure-lowering drugs in patients with advanced chronic kidney disease. Review of the literature suggests that physicians should not discard thiazide and thiazide-like diuretics as options for blood pressure management in patients with chronic advanced kidney disease.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22886538     DOI： 10.1007/s11906-012-0293-4

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


  40 in total

1.  A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension.

Authors:  Bertrand Dussol; Julie Moussi-Frances; Sophie Morange; Claude Somma-Delpero; Olivier Mundler; Yvon Berland
Journal:  Nephrol Dial Transplant       Date:  2004-12-22       Impact factor: 5.992

2.  Dose response to chlorthalidone in patients with mild hypertension. Efficacy of a lower dose.

Authors:  B J Materson; J R Oster; U F Michael; S M Bolton; Z C Burton; J E Stambaugh; J Morledge
Journal:  Clin Pharmacol Ther       Date:  1978-08       Impact factor: 6.875

3.  Thiazide-sensitive sodium chloride cotransport in early distal tubule.

Authors:  D H Ellison; H Velázquez; F S Wright
Journal:  Am J Physiol       Date:  1987-09

4.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

5.  Second Australian National Blood Pressure Study (ANBP2). Australian Comparative Outcome Trial of ACE inhibitor- and diuretic-based treatment of hypertension in the elderly. Management Committee on behalf of the High Blood Pressure Research Council of Australia.

Authors:  L M Wing; C M Reid; P Ryan; L J Beilin; M A Brown; G L Jennings; C I Johnston; J J McNeil; J E Marley; T O Morgan; J Shaw; I D Steven; M J West
Journal:  Clin Exp Hypertens       Date:  1997 Jul-Aug       Impact factor: 1.749

6.  Mechanisms of methyclothiazide-induced inhibition of contractile responses in rat aorta.

Authors:  B Colas; M Slama; T Collin; M Safar; M Andrejak
Journal:  Eur J Pharmacol       Date:  2000-11-10       Impact factor: 4.432

7.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

8.  Treatment of hypertension in the elderly. III. Response of isolated systolic hypertension to various doses of hydrochlorothiazide: results of a Department of Veterans Affairs cooperative study. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

Authors:  W C Cushman; I Khatri; B J Materson; D J Reda; E D Freis; G Goldstein; E A Ramirez; F N Talmers; T J White; S Nunn
Journal:  Arch Intern Med       Date:  1991-10

9.  Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure.

Authors:  H Knauf; E Mutschler
Journal:  J Cardiovasc Pharmacol       Date:  1995-09       Impact factor: 3.105

Review 10.  Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability.

Authors:  Barry L Carter; Michael E Ernst; Jerome D Cohen
Journal:  Hypertension       Date:  2003-11-24       Impact factor: 10.190
View more
  7 in total

Review 1.  Thiazide Diuretics in Chronic Kidney Disease.

Authors:  Arjun D Sinha; Rajiv Agarwal
Journal:  Curr Hypertens Rep       Date:  2015-03       Impact factor: 5.369

Review 2.  Diuretics in the treatment of hypertension.

Authors:  Douglas L Blowey
Journal:  Pediatr Nephrol       Date:  2016-03-16       Impact factor: 3.714

3.  A Randomized Trial of Distal Diuretics versus Dietary Sodium Restriction for Hypertension in Chronic Kidney Disease.

Authors:  Dominique M Bovée; Wesley J Visser; Igor Middel; Anneke De Mik-van Egmond; Rick Greupink; Rosalinde Masereeuw; Frans G M Russel; A H Jan Danser; Robert Zietse; Ewout J Hoorn
Journal:  J Am Soc Nephrol       Date:  2020-01-29       Impact factor: 10.121

Review 4.  Type 2 Diabetes and Thiazide Diuretics.

Authors:  André J Scheen
Journal:  Curr Diab Rep       Date:  2018-02-05       Impact factor: 4.810

5.  Tag polymorphisms of solute carrier family 12 member 3 gene modify the risk of hypertension in northeastern Han Chinese.

Authors:  Y L Wang; Y Qi; J N Bai; Z M Qi; J R Li; H Y Zhao; Y F Wang; C Z Lu; Y Xiao; N Jia; B Wang; W Q Niu
Journal:  J Hum Hypertens       Date:  2014-01-16       Impact factor: 3.012

Review 6.  Management of hypertension in chronic kidney disease.

Authors:  Raymond R Townsend; Sandra J Taler
Journal:  Nat Rev Nephrol       Date:  2015-07-28       Impact factor: 28.314

7.  Antihypertensive therapy prescribing patterns and correlates of blood pressure control among hypertensive patients with chronic kidney disease.

Authors:  Oyunbileg Magvanjav; Rhonda M Cooper-DeHoff; Caitrin W McDonough; Yan Gong; Mark S Segal; William R Hogan; Julie A Johnson
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-11-14       Impact factor: 3.738
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.